Be careful as its not approve yet as stated in the accouncement.
The joint venture
has been formed to market and sell the
Canntab proprietary products in
Australia with a first right to distribute throughout Asia
.
VitaCann and CannTab
will work towards having Canntab’s tablets formally approved
for sale in Australia and to export to Asia
.
Pursuant to recent and evolving legislation in Australia, the Canntab
product should qualify for approval as it should meet all the standard medical requirements that would be expected by
the medical industry and deals with the above-mentioned issues and without the problems that nearly all other Cannabis products to date have faced
.
We believe that the patents filed and pending protects
key features of our IP,and position.
- Forums
- ASX - By Stock
- Ann: MCL LEADS IN MEDICAL CANNABIS WITH CANADIAN DEAL
Be careful as its not approve yet as stated in the accouncement....
-
- There are more pages in this discussion • 430 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online